This paper investigated glycoprotein 73 (GP73) stability at +4, -20, and -80°C in citrated plasma and serum and investigated the effects of an additional freeze-thaw cycle during frozen storage.
Effect of sample type and storage conditions on Golgi membrane protein 73 stability.
Esawy MM, Shabana MA, Ahmed NH
Purpose
Conclusion
Baseline levels of GP73 were comparable in serum and citrated plasma. While GP73 levels in plasma and serum were not significantly affected by storage at 4°C for up to 72 h or at -20°C or -80°C for 6 months, GP73 declined significantly in citrated plasma and serum when stored at -20°C and thawed twice (once at 3 months and again at 6 months), but all changes were below the acceptable change limit for GP73.
Studies (1)
Purpose
This study investigated GP73 stability at +4, -20, and -80°C in citrated plasma and serum and investigated the effects of an additional freeze-thaw cycle during frozen storage. Venous blood was obtained from seven healthy patients, six patients with benign liver disease, and seven patients with newly diagnosed hepatocellular carcinoma into two Vacutainer Plus Plastic Serum Tubes and two Vacutainer Citrate Tubes. Serum was obtained by centrifugation of serum tubes at 1300 x g for 10 min and plasma by centrifugation of citrate tubes at 1500 x g for 15 min. Serum and plasma were immediately aliquoted for storage. One tube of each type was analyzed immediately and the remaining tubes were divided for storage at 4°C for 4 h, 24 h, and 72 h; at -20°C for 3 and 6 months, and at -80°C for 3 and 6 months before analysis. Additional serum and plasma aliquots were frozen at -20°C and -80°C, thawed in cold water, stored at room temperature for 30 min, and then refrozen for an additional 3 months before analysis. GP73 levels were measured using an ELISA. As the data was not normally distributed, data was analyzed using the Wilcoxon Signed Rank Test and Mann–Whitney U test and changes were compared to the acceptable change limit for GP73 calculated according to ISO 5725-6 (6.1%).
Summary of Findings
Baseline levels of GP73 were comparable in serum and citrated plasma. While GP73 levels in plasma and serum were not significantly affected by storage at 4°C for up to 72 h or at -20°C or -80°C for 6 months, GP73 declined by 5.2% in serum (P=0.03) and 2.8% in citrated plasma (P=0.004) when stored at -20°C and thawed twice (once at 3 months and again at 6 months) but all changes were below the acceptable change limit for GP73.
Biospecimens
FluidBloodFluidPlasmaFluidSerumPreservation Types
FrozenNone (Fresh)Diagnoses
NeoplasticBenignNeoplasticCarcinomaNormalPlatforms
GlycoproteinELISAPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Type of collection container/solution Citrate tubeSerum tubeBiospecimen Aliquots and Components Blood and blood products PlasmaSerumStorage Freeze/thaw cycling 0 cycles1 cycle2 cyclesStorage Storage duration 0 h24 h3 months4 h6 months72 hStorage Storage temperature -20°C-80°C4°CELISA Specific Targeted peptide/protein GP73